Hear AtLast Holdings, Inc. (HRAL)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -109.93 Thousand USD | -5.39% |
| 2022 | -104.31 Thousand USD | 37.46% |
| 2021 | -652.58 Thousand USD | 48.88% |
| 2020 | -326.3 Thousand USD | 59.77% |
| 2019 | -811.1 Thousand USD | -26936.67% |
| 2018 | -3000.00 USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 100.0% |
| 2014 | -1.07 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -42.69 Thousand USD | -24.64% |
| 2023 Q4 | -34.25 Thousand USD | -49.5% |
| 2023 FY | - USD | -5.39% |
| 2023 Q3 | -22.91 Thousand USD | 29.62% |
| 2023 Q2 | -32.55 Thousand USD | -60.98% |
| 2023 Q1 | -20.22 Thousand USD | 8.8% |
| 2022 Q4 | -22.17 Thousand USD | -10.08% |
| 2022 Q3 | -20.14 Thousand USD | 66.48% |
| 2022 Q1 | -1910.00 USD | 97.27% |
| 2022 FY | - USD | 37.46% |
| 2022 Q2 | -60.09 Thousand USD | -3046.07% |
| 2021 Q3 | -19.75 Thousand USD | 12.84% |
| 2021 Q4 | -70.04 Thousand USD | -254.63% |
| 2021 Q2 | -22.66 Thousand USD | -97.04% |
| 2021 Q1 | -11.5 Thousand USD | -38.55% |
| 2021 FY | - USD | 48.88% |
| 2020 Q2 | -289.49 Thousand USD | -1788.39% |
| 2020 Q3 | -13.44 Thousand USD | 95.36% |
| 2020 Q4 | -8300.00 USD | 38.24% |
| 2020 Q1 | -15.33 Thousand USD | 97.24% |
| 2020 FY | - USD | 59.77% |
| 2019 Q4 | -556.15 Thousand USD | -736.32% |
| 2019 FY | - USD | -26936.67% |
| 2019 Q2 | -87.62 Thousand USD | 13.1% |
| 2019 Q1 | -100.83 Thousand USD | 51.2% |
| 2019 Q3 | -66.5 Thousand USD | 24.1% |
| 2018 FY | - USD | 0.0% |
| 2018 Q4 | -206.62 Thousand USD | -27449.33% |
| 2018 Q2 | -1500.00 USD | 0.0% |
| 2018 Q3 | -750.00 USD | 50.0% |
| 2017 FY | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2015 FY | - USD | 100.0% |
| 2014 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| American Medical Technologies Inc. | -963.95 Thousand USD | 88.596% |
| Ansell Limited | 209.86 Million USD | 100.052% |
| Ansell Limited | 206.3 Million USD | 100.053% |
| BG Medicine, Inc. | - USD | Infinity% |
| Biotage AB (publ) | 42.83 Million USD | 100.257% |
| BioLife Sciences Inc. | - USD | Infinity% |
| CB Scientific, Inc. | -1.62 Million USD | 93.235% |
| Psykey, Inc. | -1.29 Million USD | 91.513% |
| ConvaTec Group Plc | 455.5 Million USD | 100.024% |
| ConvaTec Group Plc | 455.5 Million USD | 100.024% |
| Encision Inc. | -544.19 Thousand USD | 79.8% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 22.481% |
| Innovative MedTech Inc. | -7.67 Million USD | 98.567% |
| LifePoint, Inc. | -14.2 Million USD | 99.226% |
| Medite Cancer Diagnostics, Inc. | -6.18 Million USD | 98.223% |
| Paradigm Medical Industries, Inc. | -325 Thousand USD | 66.175% |
| QuantRx Biomedical Corporation | - USD | Infinity% |
| Remedent, Inc. | -215.23 Thousand USD | 48.925% |
| Reflect Scientific, Inc. | -405.78 Thousand USD | 72.909% |
| SmileDirectClub, Inc. | -186.13 Million USD | 99.941% |
| Sector 10, Inc. | - USD | Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 447.82 Million USD | 100.025% |
| SheerVision, Inc. | -110.53 Thousand USD | 0.544% |
| United Health Products, Inc. | -2.5 Million USD | 95.607% |
| Vasamed, Inc. | -4.57 Million USD | 97.597% |
| Wearable Health Solutions, Inc. | -2.26 Million USD | 95.137% |
| Yubo International Biotech Limited | -1.17 Million USD | 90.666% |